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CORRESPONDENCE
Letters to the Editor
Effect of Polyunsaturated
Fatty Acids on Baroreflex
Function in Heart Failure Patients
Recently in the Journal, Radaelli et al. (1) reported that 4 months
of dietary polyunsaturated fatty acid (PUFA) supplementation
enhanced baroreflex control of the circulation in heart failure
patients. Augmented cardiac-vagal baroreflex control was sug-
gested from increased bradycardiac responses to neck suction as
well as enhanced cardiac period fluctuations during spontaneous
blood pressure oscillations after PUFA supplementation. These
effects of PUFAs on the cardiac-vagal arm of the baroreflex in
heart failure patients were impressive and may be of clinical
importance.
Based on the detrimental role sympathoexcitation is believed to
exert in heart failure, a separate but equally important question is
the effect that PUFAs exert on both basal and reflexive measures of
sympathetic outflow. To address this question, Radaelli et al. (1)
used several indirect indices. First, increased low frequency heart
rate variability after PUFA supplementation was used as evidence
of reduced sympathetic activity at rest (1). Second, a greater
depressor response to neck suction, which likely is mediated via
both cardiac (vagal and sympathetic) and peripheral (sympathetic)
effects, after PUFA supplementation, was suggested to indicate
enhanced sympathoinhibitory baroreflex function (1). As pointed
out, these effects of PUFAs in heart failure patients may need to be
confirmed using more robust measures of sympathetic outflow, which
should also include responses to sympathoexcitatory stimuli (2).
To date, only a single study performed in humans has deter-
mined the effect that PUFA supplementation exerts on a direct
measure of sympathetic outflow (muscle sympathetic nerve activity
[MSNA]) (3). In that study we demonstrated that PUFA supple-
mentation had no effect on MSNA at rest (against our hypothesis
that it would reduce it). Furthermore, we observed augmented (not
depressed as we hypothesized) increases in MSNA during several
distinct sympathoexcitatory stressors (exercise and cold stress) in
young healthy adults (3). Because sympathetic outflow at rest is
increased and reflex responses to baroreflex activation/deactivation
may be impaired in heart failure patients, it is unclear whether
similar effects of PUFAs on MSNA would be observed in heart
failure patients. Accordingly, it appears that studies employing
more robust methodologies are needed to more definitively deter-
mine the effect that PUFAs exert on basal and reflexive (both
sympathoinhibitory and sympathoexcitatory during baroreflex and
nonbaroreflex stimuli) regulation of sympathetic outflow in heart
failure patients.
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Reply
We appreciate the comments by Drs. Monahan and Ray concern-
ing our suggestion that, in heart failure patients, polyunsaturated
fatty acid (PUFA) supplementation may attenuate efferent sym-
pathetic nerve overactivity (SNA) (1). We entirely agree that this
issue is of potential clinical relevance and merits direct experimen-
tal testing, as indicated in the discussion of our own study and
reinforced by Floras and Bagai in their accompanying editorial (2).
This question is made even more interesting because, as
appropriately recalled by our colleagues, they previously observed
(3) that PUFA supplementation failed to modify resting muscle
SNA in healthy individuals. Conversely, we all perfectly realize
that the two possibilities (no change in the healthy subject,
reduction in the heart failure patient) are by no means mutually
exclusive considering that regulation of autonomic ouflows is
significantly altered in cardiac systolic dysfunction, and may thus
be differentially affected by PUFA supplementation compared to
the normal condition.
While awaiting more direct evidence (cardiac norepinephrine
spillover? peroneal microneurography? metaiodobenzylguanidine
cardiac scans?), all we can do is to contemplate the most reasonable
interpretation of the indirect evidence emerging from our study,
namely that PUFA 1) increased both low- and high-frequency
powers of the RR interval; 2) potentiated cardiovascular inhibitory
control by the baroreflex; 3) fell short of significantly slowing heart
rate; and 4) markedly enhanced overall RR interval variability.
Each of the previously-cited effects points to a PUFA-related
reduction in sympathetic (and probably an enhanced vagal) nerve
activity.
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Use of Electrocardiographic
Gating in Computed
Tomography Angiography
of the Ascending Thoracic Aorta
We congratulate Hendel et al. (1) on their detailed documentation
of appropriateness criteria for cardiac computed tomography (CT)
and cardiac magnetic resonance imaging, which they published in
the October 3, 2006, issue of the Journal. We are, however,
concerned regarding the apparent recommendation for use of
non-electrocardiographic (ECG)-gated CT angiography in the
evaluation of potential aortic dissection (Tables 8 and 10 in Hendel
et al. [1]).
The aortic root and ascending thoracic aorta move in concert
with the left ventricle and have the greatest motion during systole.
It is well documented that motion artifacts from aortic wall motion
can simulate the appearance of a dissection flap, particularly in the
aortic root and ascending thoracic aorta, leading to an erroneous
diagnosis of ascending aortic dissection (2–4). The prevalence of
this finding is described as being as high as 57% in non–ECG-
gated CT angiographic studies (5).
The use of ECG gating (either prospective or retrospective
gating) has been shown to effectively “freeze” cardiac pulsation and
aortic wall motion and to reduce motion artifacts when compared
to results of non–ECG-gated studies (6,7). Furthermore, the
application of ECG gating by adequately trained technologists has
no impact on the workflow of the CT examination (7). In our own
practice, we prefer the use of prospective ECG gating to minimize
radiation exposure to our patients.
Therefore, we believe that ECG gating should be mandatory for
thoracic aortic CT angiograms performed to detect potential aortic
dissection. We hope that the investigators agree and will promptly
make this critical and appropriate correction.
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Reply
We thank Drs. Cheong and Flamm for their concern about the use
of nonelectrocardiographic (ECG)-gated computed tomographic
angiography (CTA) in the evaluation of potential aortic dissection
in the latest Appropriateness Criteria document (1). The Ameri-
can College of Cardiology Foundation Appropriateness Criteria
Working Group has reviewed their letter, which was forwarded by
the editor of JACC for our consideration.
Drs. Cheong and Flamm certainly raise an important point. To
clarify, the listing of the indications and the technology used is not
a “recommendation” for the use of non–ECG-gated CTA in the
evaluation of potential aortic dissection. Instead, the expert panel
rated the use of this technology as “appropriate” for the evaluation
of aortic dissection. We certainly agree that, in many situations,
the use of ECG gating would also be “appropriate” and likely
would provide better image quality for assessing the relationship of
an intimal flap with the structures of the aortic root, including the
coronary arterial ostea. Depending on the method of ECG gating
(retrospective vs. prospective), this may come at the cost of
increased radiation exposure to the patient. The indications and
specific imaging techniques as listed were not meant to be
exhaustive, and the use of ECG gating was not purposefully
excluded.
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